Nyxoah (NYXH) Competitors

Embecta (NASDAQ:EMBC) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

Does the media prefer EMBC or NYXH?

In the previous week, Embecta had 4 more articles in the media than Nyxoah. MarketBeat recorded 10 mentions for Embecta and 6 mentions for Nyxoah. Embecta's average media sentiment score of 1.41 beat Nyxoah's score of -0.17 indicating that Embecta is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Embecta	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Nyxoah	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Is EMBC or NYXH more profitable?

Embecta has a net margin of 7.58% compared to Nyxoah's net margin of -1,541.84%. Embecta's return on equity of -23.40% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Embecta	7.58%	-23.40%	14.46%
Nyxoah	-1,541.84%	-79.18%	-54.92%

Do analysts rate EMBC or NYXH?

Embecta presently has a consensus price target of $19.00, indicating a potential upside of 30.23%. Nyxoah has a consensus price target of $15.00, indicating a potential upside of 143.11%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts plainly believe Nyxoah is more favorable than Embecta.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Nyxoah	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders and institutionals believe in EMBC or NYXH?

93.8% of Embecta shares are held by institutional investors. 0.4% of Embecta shares are held by insiders. Comparatively, 17.1% of Nyxoah shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has better earnings & valuation, EMBC or NYXH?

Embecta has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.12B	0.76	$78.30M	$1.43	10.20
Nyxoah	$4.89M	42.98	-$64.10M	-$2.30	-2.68

Which has more volatility & risk, EMBC or NYXH?

Embecta has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500.

Summary

Embecta beats Nyxoah on 10 of the 16 factors compared between the two stocks.